Thu. 18 Apr 2024, 7:11am ET
Benzinga
Biotech, News, Health Care, General
Longitudinal Study of a 200+ Real-World Patient Cohort Further Validates CCL24 as a Novel Target for Systemic Sclerosis (SSc), Showing that It is Associated with Disease Severity Across the Fibrotic and Vascular Manifestations of SSc